| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355269 Oral compositions of levosimendan |
| 03/12/2002 | US6355268 Liposome-entrapped topoisomerase inhibitors |
| 03/12/2002 | US6355267 Liposome preparation and material encapsulation method |
| 03/12/2002 | US6355266 Indomethacin-containing patch; for theray of pain due to contusion, sprain or muscular fatigue, and pain associated with shoulder stiffness |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355243 Method of thrombolysis by local delivery of active plasmin |
| 03/12/2002 | US6355198 Method of forming articles including waveguides via capillary micromolding and microtransfer molding |
| 03/12/2002 | CA2347330C Liquid injectable formulation of disodium pamidronate |
| 03/12/2002 | CA2313783C Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof |
| 03/12/2002 | CA2228091C Preparation used in dental care |
| 03/12/2002 | CA2187214C Aminostilbazole derivative and medicine |
| 03/12/2002 | CA2098913C Aqueous vaginal douche and related methods |
| 03/12/2002 | CA2047944C Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
| 03/12/2002 | CA2032581C Hydrolytically degradable hydrophilic gels and the method for preparation thereof |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018450A1 New cross-linked derivatives of hyaluronic acid |
| 03/07/2002 | WO2002018015A1 Natural, non-allergenic, immune system stimulant |
| 03/07/2002 | WO2002018001A2 Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
| 03/07/2002 | WO2002017983A1 Medicinal compositions for forming tissue around bone or tooth, process for preparing the same, injections for forming tissue around bone or tooth and process for preparing the same |
| 03/07/2002 | WO2002017971A1 Slow release pharmaceutical preparation and method of administering same |
| 03/07/2002 | WO2002017967A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | WO2002017966A1 Antacid chewing gum products coated with high viscosity materials |
| 03/07/2002 | WO2002017932A1 Oct preparations |
| 03/07/2002 | WO2002017928A2 Transdermal therapeutic system for releasing exemestane |
| 03/07/2002 | WO2002017927A1 Method for treating erectile dysfunction and increasing libido in men |
| 03/07/2002 | WO2002017926A1 Pharmaceutical composition and method for treating hypogonadism |
| 03/07/2002 | WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | WO2002017921A2 Paroxetine compositions and processes for making the same |
| 03/07/2002 | WO2002017920A2 Use of methylphenidate compounds to enhance memory |
| 03/07/2002 | WO2002017919A2 Use of threo-methylphenidate compounds to enhance memory |
| 03/07/2002 | WO2002017918A2 Sustained release formulations for growth hormone secretagogues |
| 03/07/2002 | WO2002017907A1 Method for enhanced delivery of oxybutynin and compositions thereof |
| 03/07/2002 | WO2002017905A2 Treatment of burns |
| 03/07/2002 | WO2002017894A2 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 03/07/2002 | WO2002017892A2 Water-dispersible encapsulated sterols |
| 03/07/2002 | WO2002017889A1 Transdermal therapeutic system for releasing venlafaxine |
| 03/07/2002 | WO2002017888A2 Controlled and sustained release properties of polyelectrolyte multilayer capsules |
| 03/07/2002 | WO2002017887A1 Medicament for treating intestinal diseases |
| 03/07/2002 | WO2002017886A1 Pectin film compositions |
| 03/07/2002 | WO2002017885A2 Controlled release formulation of erythromycin or a derivative thereof |
| 03/07/2002 | WO2002017884A1 Dextran hydrogels |
| 03/07/2002 | WO2002017883A2 Milled particles |
| 03/07/2002 | WO2002017882A1 Solid peptide preparations for inhalation, and the production thereof |
| 03/07/2002 | WO2002017881A2 Transdermal pharmaceutical delivery composition |
| 03/07/2002 | WO2002017879A1 Palatable oral coenzyme q liquid |
| 03/07/2002 | WO2002017878A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | WO2002017877A2 Controlled release pharmaceutical pellet compositions for reducing side effects of drugs |
| 03/07/2002 | WO2002017870A2 Clear antiperspirants and deodorants made with siloxane-based polyamides |
| 03/07/2002 | WO2002017857A2 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | WO2002017855A2 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 03/07/2002 | WO2002017853A2 Hyaluronan-based antiadhesion compositions, their preparation and use |
| 03/07/2002 | WO2002017848A1 Hard capsule |
| 03/07/2002 | WO2002017831A2 Devices for intraocular drug delivery |
| 03/07/2002 | WO2002017816A1 Methods and compositions for tissue augmentation |
| 03/07/2002 | WO2002017735A2 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 03/07/2002 | WO2002017713A1 Collagen/polysaccharide bilayer matrix |
| 03/07/2002 | WO2001093911A3 Macromolecular drug complexes and compositions containing the same |
| 03/07/2002 | WO2001089474A3 O/w emulsion |
| 03/07/2002 | WO2001087329A8 Liquid pharmaceutical composition containing an erythropoietin derivate |
| 03/07/2002 | WO2001087232A3 Allantoin-containing skin cream |
| 03/07/2002 | WO2001082867A3 A core formulation |
| 03/07/2002 | WO2001068052A3 Phosphate based biodegradable polymers |
| 03/07/2002 | WO2001066697A3 Serum free cultivation of primate embryonic stem cells |
| 03/07/2002 | WO2001064187B1 Anaesthetic formulations |
| 03/07/2002 | WO2001062227A3 Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease |
| 03/07/2002 | WO2001060414A3 Genetic modification of the lung as a portal for gene delivery |
| 03/07/2002 | WO2001060407A3 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 03/07/2002 | WO2001058408A3 Multi-purpose drug and heat therapy treatment system |
| 03/07/2002 | WO2001055092B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 03/07/2002 | WO2001052824A3 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 03/07/2002 | WO2001051040B1 Osmotic device containing alprazolam and an antipsychotic agent |
| 03/07/2002 | WO2001049261A3 Stable aqueous deoxyfructosazine solution |
| 03/07/2002 | WO2001041758A3 Valnemulin formulation |
| 03/07/2002 | WO2001036039A3 Iontophoretic transdermal delivery of peptides |
| 03/07/2002 | WO2001035932A3 Sustained drug delivery from structural matrices |
| 03/07/2002 | WO2001028591A3 Injection vehicle for polymer-based formulations |
| 03/07/2002 | WO2001023377A3 Polymorphic salt |
| 03/07/2002 | WO2001021163A3 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/07/2002 | US20020028846 Compositions and methods for amelioration of human female sexual dysfunction |
| 03/07/2002 | US20020028843 Mupirocin calcium amorphous as a microbiocide dissolved in a hydrophilic solvent, preferably, hexamethylene glycol; heat resistance; skin, ear and eye disorders; topical and nasal |
| 03/07/2002 | US20020028816 Containing antibiotics such as moxifloxacin; treating infections of Microbacterium species Microbacterium otitidis and Microbacterium alconae |
| 03/07/2002 | US20020028798 Analgesics, antiinflammatory agents; mixture containing enzyme inhibitor |
| 03/07/2002 | US20020028794 Aqueous suspension; dietetics |
| 03/07/2002 | US20020028793 Antilipemic agents, anticholesterol agents, anticoagulants |
| 03/07/2002 | US20020028789 Topical pain relief composition and carrier |
| 03/07/2002 | US20020028788 Administering estradiol in cyclodextrin adjuvant |
| 03/07/2002 | US20020028780 Antiparasitic formulations |
| 03/07/2002 | US20020028775 Using mixture of flavonoids, cytochrome inhibitor, sugar, phosphate in carrier |
| 03/07/2002 | US20020028770 Bactericides |
| 03/07/2002 | US20020028769 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 03/07/2002 | US20020028766 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/07/2002 | US20020028515 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 03/07/2002 | US20020028330 Switchable tackiness coating compositions for ophthalmic implants |
| 03/07/2002 | US20020028276 Sugar-free products with improved characteristics |
| 03/07/2002 | US20020028252 Multifluid atomization of a dispersed system of a biologically active agent and a solvent to produce droplets; freezing the droplets; lyophilizing the frozen droplets obtain microstructures capable of being further fragmented |
| 03/07/2002 | US20020028250 Carbon-substituted diketopiperazine delivery systems |
| 03/07/2002 | US20020028249 Preparation of biodegradable, biocompatible microparticles containing a biolgically active agent |
| 03/07/2002 | US20020028248 Rapid-release microdispersible ecadotril preparation |